Table 3.
Maternal values of neonatal outcomes favoring different therapeutic indomethacin options
| Outcome | Women favored prophylactic approach Mean (SD) | Women favored symptomatic approach Mean (SD) | Mean difference (95% CI) | p- value |
|---|---|---|---|---|
| PDA | 41 (21) | 44 (24) | −3 (−9, 3) | 0.3 |
| IVH | 28 (23) | 35 (25) | −7 (−14, −0,3) | 0.04 |
| BPD | 35 (22) | 40 (23) | −5 (−12, 1) | 0.11 |
| PDA ligation | 38 (24) | 39 (30) | −1 (−9, 6) | 0.7 |
| Oliguria | 63 (22) | 55 (21) | 8 (2, 15) | 0.01 |
| Neurosensory outcome | 65 (27) | 58 (24) | 7 (−1,14) | 0.09 |
BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage; PDA, patent ductus arteriosus.